CYPRESS BIOSCIENCE INC. CYPB (NASDAQ)

(NEW YORK)Forest Laboratories Inc. and Cypress Bioscience Inc. said Monday the Food and Drug Administration will delay reviewing their application for a prospective fibromylagia drug, but ha...READ MORE

(WASHINGTON)Shares of Cypress Bioscience jumped Thursday as the deadline for an approval decision on the company's lead product draws closer. The Food and Drug Administration is scheduled to m...READ MORE

Among the stock activity stories for Thursday, Sept. 25, from AP Financial News: NEW YORK (AP)--Six Flags Inc.'s shares plunged on Thursday after Moody's Investors Services downgra...READ MORE

(SAN DIEGO)Drug developer Cypress Bioscience Inc. said Friday it swung to a loss in the second quarter, as revenue from collaborations fell sharply compared with a year ago.READ MORE

Among the stock activity stories for Monday, June 16, from AP Financial News: NEW YORK (AP)--Shares of Exelixis Inc. rose Monday, after the biopharmaceutical company reached an agr...READ MORE

(NEW YORK)Shares of Cypress Bioscience Inc. surged Monday, as analysts said the Food and Drug Administration's approval of Eli Lilly & Co.'s antidepressant Cymbalta as a treatment fo...READ MORE

(SAN DIEGO, Calif.)Cypress Bioscience Inc. Monday said that its first-quarter loss widened on an increase in operating expenses stemming from the drug developer's acquisition of Propius Pharmaceu...READ MORE